UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934

Date of report (Date of earliest event reported): ~~May~~June 298, 2026

Oscar Health, Inc.

(Exact Name of Registrant as Specified in its Charter)

Delaware

001-40154

46-1315570

(State or Other Jurisdiction

of Incorporation)

(Commission

File Number)

(IRS Employer

Identification No.)

75 Varick Street, 5th Floor

New York, New York 10013

(Address of Principal Executive Offices) (Zip Code)

(646) 403-3677

(Registrant’s telephone number, including area code)

Not applicable

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:


☐			Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425).


☐			Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12).


☐			Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)).


☐			Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)).

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading

Symbols

Name of each exchange

on which registered

Class A Common Stock, $0.00001 par value per share

OSCR

New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 57.0201. ~~Departure~~Regulation ofFD ~~Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers~~Disclosure.

~~On May 29, 2026,~~ Oscar Health, Inc. ~~and Oscar Management Corporation~~ (~~together,~~ the “Company”) ~~and~~will ~~Mario~~participate ~~Schlosser~~in ~~entered~~a ~~into~~fireside anchat ~~amended~~at ~~and~~the ~~restated~~Goldman ~~employment~~Sachs ~~agreement~~47th Annual Global Healthcare Conference (the “~~A&R Employment Agreement~~Conference”), ~~effective~~on ~~as of~~ June 18, 2026 ~~(the~~at ~~“Effective~~approximately ~~Date”),~~11:20 inAM ~~connection with Mr~~ET. ~~Schlosser’s~~At ~~transition~~the ~~from~~Conference, ~~President~~the ofCompany ~~Technology~~plans ~~and~~to ~~Chief~~provide ~~Technology~~a ~~Officer~~business ofupdate ~~the~~and ~~Company~~reaffirm toits ~~Co-Founder~~full &year ~~Advisor~~2026 toguidance, ~~the~~as ~~CEO.~~previously Inprovided ~~this~~in ~~new~~its ~~role,~~financial ~~Mr.~~results ~~Schlosser~~press ~~will~~release ~~continue~~dated ~~accelerating~~February ~~the~~10, ~~Company’s~~2026. ~~artificial~~A ~~intelligence~~live ~~and~~audio ~~digital~~webcast ~~health~~will ~~agenda~~be toavailable ~~drive~~via the ~~next~~Investor ~~wave~~Relations page of ~~innovation~~the inCompany’s ~~consumer-driven~~website ~~healthcare~~at ~~across the U~~ir.Shioscar.com, ~~Mr.~~and ~~Schlosser~~a replay will ~~also~~be ~~continue~~available tofor ~~serve~~approximately on90 ~~the~~days ~~Company’s~~following ~~Board~~the ~~of Directors~~event.

~~The~~This ~~term~~information shall not be deemed “filed” for purposes of Section 18 of the ~~A&R~~Securities ~~Employment~~Exchange ~~Agreement~~Act ~~commences~~of on1934, as amended (the ~~Effective~~“Exchange ~~Date~~Act”), ~~and~~or ~~will~~incorporated ~~continue~~by ~~until~~reference in any filing under the ~~agreement~~Securities ~~terminates~~Act inof ~~accordance~~1933, ~~with~~as ~~its~~amended, ~~terms~~or the Exchange Act, except as expressly set forth by specific reference in any such filing.

~~The~~Cautionary ~~material~~Note ~~changes~~Regarding ~~under~~Forward-Looking ~~the A&R Employment Agreement are as follows:~~ Statements

~~•Mr~~This Current Report on Form 8-K contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. ~~Schlosser’s~~All ~~annual~~statements ~~base~~other ~~salary~~than ~~will~~statements beof ~~$370~~historical fact contained herein are forward- looking statements. These statements include,~~000~~ but are not limited to, ~~effective~~statements about our expected financial performance and upcoming events and presentations. Accordingly, we caution you that any such forward-looking statements are not guarantees of future performance and are subject to risks, assumptions, and uncertainties that are difficult to predict and generally beyond our control. Although management believes that the expectations reflected in these forward-looking statements are reasonable as of the ~~Effective~~date ~~Date~~made, there are or will be important factors that could cause our actual results to differ materially from those indicated in these forward-looking statements, including, but not limited to, the factors set forth under the caption “Risk Factors” in our in our Annual Report on Form 10-K for the year ended December 31, 2025, filed with the Securities and Exchange Commission (“SEC”), and our other filings with the SEC, including our Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2026, filed with the SEC.

~~•Commencing~~You ~~with~~are ~~calendar~~cautioned ~~year~~not ~~2026,~~to Mrplace undue reliance on any forward-looking statements made in this Form 8-K. ~~Schlosser~~Any ~~will~~forward-looking nostatement ~~longer~~speaks beonly ~~eligible~~as of the date as of which it is made, and, except as otherwise required by law, we do not undertake any obligation to ~~receive~~publicly anupdate ~~annual~~or ~~bonus~~review ~~under~~any ~~the~~forward-looking ~~Company’s~~statement, ~~annual~~whether ~~bonus~~as ~~program~~a result of new information, future developments or otherwise. New factors emerge from time to time, and it is not possible for us to predict which will arise.

•Mr. Schlosser will not be eligible to receive any long-term incentive or equity-based compensatory awards during the term of the A&R Employment Agreement, but will continue to vest in the equity awards previously granted to him in accordance with their terms.

•Mr. Schlosser will not be entitled to receive any cash severance payments or Company-subsidized healthcare coverage upon any termination of employment with the Company.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Oscar Health, Inc. By: /s/ ~~Adam~~R. ~~McAnaney~~Scott Blackley Name: ~~Adam~~R. ~~McAnaney~~Scott Blackley Title: Chief ~~Legal~~Financial Officer

Date: June 28, 2026

Filing Compare · Oscar Health, Inc.